Home / Sports / WNBA, FIBA Clash on Transgender Rules
WNBA, FIBA Clash on Transgender Rules
4 Sep
Summary
- WNBA eligibility hinges on being 'woman' without clear definition.
- FIBA requires genetic screening for elite transgender athletes.
- FIBA committee to recommend on transgender eligibility by 2027.
Ahead of the 2026 World Cup, the WNBA and FIBA are implementing differing policies regarding transgender athlete eligibility. The WNBA's current Collective Bargaining Agreement simply states that players must be 'woman,' offering no explicit definition or criteria, which has led to ambiguity and potential exploitation.
FIBA, however, has established a stricter policy for its elite sanctioned events, including the World Cup. Their guidelines, aligning with the International Olympic Committee's framework, necessitate genetic or biological screening, such as testing for the SRY gene or XX chromosomes. This policy has effectively closed the door on transgender athlete participation for now.
Despite these measures, FIBA is actively gathering more data. A specialized Gender Eligibility Committee, comprising medical and legal experts, is tasked with further evaluation. This committee is expected to present its recommendations to the FIBA Central Board at the beginning of 2027, after which transgender eligibility requests will be considered.
The WNBA's approach, characterized by its reliance on the broad 'woman' stipulation, faces increasing scrutiny amid public discourse and attempts by figures to challenge existing rules. The lack of specific therapeutic exemptions or detailed guidelines in the WNBA's agreement suggests a need for clearer definitions as the sports world grapples with evolving inclusion standards.
